Blood and CSF homocysteine levels in Alzheimer's disease: A meta-analysis and meta-regression of case–control studies

L Zhang, X Xie, Y Sun, F Zhou - Neuropsychiatric Disease and …, 2022 - Taylor & Francis
Objective Hyperhomocysteinemia (HHcy), as an important risk factor for Alzheimer's disease
(AD), would aggravate cognitive dysfunction. This study aimed to investigate whether and to …
被引用次数：11 相关文章
[PDF] scienceopen.com

[PDF][PDF] Blood and CSF Homocysteine Levels in Alzheimer's Disease: A Meta-Analysis and Meta-Regression of Case–Control Studies

L Zhang, X Xie, Y Sun, F Zhou - Neuropsychiatric Disease and …, 2022 - scienceopen.com
Objective: Hyperhomocysteinemia (HHcy), as an important risk factor for Alzheimer's
disease (AD), would aggravate cognitive dysfunction. This study aimed to investigate …

Blood and CSF Homocysteine Levels in Alzheimer's Disease: A Meta-Analysis and Meta-Regression of Case-Control Studies.

L Zhang, X Xie, Y Sun, F Zhou - Neuropsychiatric Disease and …, 2022 - europepmc.org
Objective Hyperhomocysteinemia (HHcy), as an important risk factor for Alzheimer's disease
(AD), would aggravate cognitive dysfunction. This study aimed to investigate whether and to …

Blood and CSF Homocysteine Levels in Alzheimer's Disease: A Meta-Analysis and Meta-Regression of Case–Control Studies

L Zhang, X Xie, Y Sun, F Zhou - Neuropsychiatric Disease and …, 2022 - search.proquest.com
Objective: Hyperhomocysteinemia (HHcy), as an important risk factor for Alzheimer's
disease (AD), would aggravate cognitive dysfunction. This study aimed to investigate …

Blood and CSF Homocysteine Levels in Alzheimer's Disease: A Meta-Analysis and Meta-Regression of Case–Control Studies.

L Zhang, X Xie, Y Sun, F Zhou - Neuropsychiatric Disease & …, 2022 - search.ebscohost.com
Abstract aimed to investigate whether and to what degree the homocysteine (Hcy) levels in
blood and cerebrospinal fluid (CSF) were elevated in AD patients compared with healthy …
[HTML] nih.gov

[HTML][HTML] Blood and CSF Homocysteine Levels in Alzheimer's Disease: A Meta-Analysis and Meta-Regression of Case–Control Studies

L Zhang, X Xie, Y Sun, F Zhou - Neuropsychiatric Disease and …, 2022 - ncbi.nlm.nih.gov
Objective Hyperhomocysteinemia (HHcy), as an important risk factor for Alzheimer's disease
(AD), would aggravate cognitive dysfunction. This study aimed to investigate whether and to …
[PDF] semanticscholar.org

[PDF][PDF] Blood and CSF Homocysteine Levels in Alzheimer's Disease: A Meta-Analysis and Meta-Regression of Case–Control Studies

L Zhang, X Xie, Y Sun, F Zhou - … Disease and Treatment, 2022 - pdfs.semanticscholar.org
Objective: Hyperhomocysteinemia (HHcy), as an important risk factor for Alzheimer's
disease (AD), would aggravate cognitive dysfunction. This study aimed to investigate …

Blood and CSF Homocysteine Levels in Alzheimer's Disease: A Meta-Analysis and Meta-Regression of Case-Control Studies

L Zhang, X Xie, Y Sun, F Zhou - … disease and treatment, 2022 - pubmed.ncbi.nlm.nih.gov
Objective Hyperhomocysteinemia (HHcy), as an important risk factor for Alzheimer's disease
(AD), would aggravate cognitive dysfunction. This study aimed to investigate whether and to …

Blood and CSF Homocysteine Levels in Alzheimer's Disease: A Meta-Analysis and Meta-Regression of Case–Control Studies

L Zhang, X Xie, Y Sun, F Zhou - Neuropsychiatric Disease and …, 2022 - dovepress.com
Objective: Hyperhomocysteinemia (HHcy), as an important risk factor for Alzheimer's
disease (AD), would aggravate cognitive dysfunction. This study aimed to investigate …

[引用][C] Blood and CSF Homocysteine Levels in Alzheimer's Disease: A Meta-Analysis and Meta-Regression of Case–Control Studies

L Zhang, X Xie, Y Sun, F Zhou - Neuropsychiatric Disease and …, 2022 - europepmc.org
Objective: Hyperhomocysteinemia (HHcy), as an important risk factor for Alzheimer's
disease (AD), would aggravate cognitive dysfunction. This study aimed to investigate …